Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Hyaluronidase

Rachel L. Murray, Anoosh Zafar Gondal  1
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Hyaluronidase

Rachel L. Murray et al.
Free Books & Documents

Excerpt

Hyaluronidase is an enzyme useful in facilitating the management of injectable medications. This activity reviews the indications, action, adverse effects, and contraindications for hyaluronidase as an important adjuvant therapy for patients requiring subcutaneous injections. This activity will highlight the mechanism of action, adverse event profile, and other key factors pertinent to members of the interprofessional team in the care of patients with chronic injection therapy.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Rachel Murray declares no relevant financial relationships with ineligible companies.

Disclosure: Anoosh Zafar Gondal declares no relevant financial relationships with ineligible companies.

References

    1. Bittner B, Richter W, Schmidt J. Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities. BioDrugs. 2018 Oct;32(5):425-440. - PMC - PubMed
    1. Khan N, Niazi ZR, Rehman FU, Akhtar A, Khan MM, Khan S, Baloch N, Khan S. Hyaluronidases: A Therapeutic Enzyme. Protein Pept Lett. 2018;25(7):663-676. - PubMed
    1. Wasserman RL. Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases. Immunotherapy. 2017 Sep;9(12):1035-1050. - PubMed
    1. Wong KM, Horton KJ, Coveler AL, Hingorani SR, Harris WP. Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20). Curr Oncol Rep. 2017 Jul;19(7):47. - PubMed
    1. Spandorfer PR, Mace SE, Okada PJ, Simon HK, Allen CH, Spiro DM, Friend K, Harb G, Lebel F, Increased Flow Utilizing Subcutaneously-Enabled Pediatric Rehydration II (INFUSE-Peds II) Study Group A randomized clinical trial of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in mild to moderately dehydrated children in the emergency department. Clin Ther. 2012 Nov;34(11):2232-45. - PubMed

Publication types

LinkOut - more resources